Expand Your Abilities.

Genotix (jen-ˈō-tiks) breakthrough technology—Liquid Nanoarray Digital Assay (LINARDA)—is at the core of our offering. LINARDA enables digital detection of single proteins or nucleic acids by flow cytometry analysis of biomarker-linked nanoparticle complexes. 

LINARDA technology employs the use of proprietary monodispersed fluorescent nanoparticles, select antibodies or probes, and advanced buffer and sheath hydrodynamics to enable high-resolution particle characterization. Nanoparticle complexes move through a flow chamber, where a laser excitation characterizes and quantitates biomarker complexes, enabling single-molecule registration.

This technology allows you to analyze protein or nucleic acid composition in liquid specimens at single-analyte resolution in under two hours.